DanCann Pharma A/S publishes Annual Report 2021
COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2021. The annual report is available after today's trading on the Spotlight Stock Market, and hereby available in this press release and on the website of DanCann Pharma.For more information, visit: https://www.dancann.com/investor-relations-ir/general-meetings. Disclaimer Some statements in this release